Blog Category

Press Releases

Biophytis Trading will resume on February 14th, 2020 at 09:00 CET

,

/

14 February 2020

Biophytis successfully completes a € 3.3 million capital increase to strengthen its financing structure

,

/

14 February 2020

Biophytis shares trading is suspended pending a new press release

,

/

13 February 2020

Protocol Amendment of SARA-INT, a Phase 2b Clinical Trial of Sarconeos (BIO101) in Sarcopenia, Cleared by FDA and AFMPS

,

/

11 February 2020

Biophytis SARA-INT Phase 2b study, evaluating the efficacy of Sarconeos (BIO101) in sarcopenia, has now achieved over 50% patient recruitment

,

/

27 January 2020

Biophytis announces the issuance of a €3 million tranche of ORNANEBSA

,

/

10 January 2020

Biophytis has appointed Evelyne Nguyen as CFO and Strengthens Senior Management Team

,

/

2 January 2020